Intellia Therapeutics Inc
- Stock Issuer and Owners
Intellia Therapeutics Inc |
Ticker | NTLA |
CIK # | 0001652130 |
CUSIP | 45826J105 |
Sector | Life Sciences - In Vitro & In Vivo Diagnostic Substances |
Address | 130 Brookline Street Suite 201, Cambridge, MA 02139 |
Source |
[EDGAR]
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
ARK Investment Management LLC |
[2023-03-31]
|
SOLE |
8,951,987.0 |
9,837,166.0 |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
7,940,602.0 |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
7,189,858.0 |
7,348,294.0 |
State Street Corp |
[2023-03-31]
|
DFND |
3,349,996.0 |
3,539,638.0 |
Sumitomo Mitsui Trust Holdings, Inc. |
[2023-03-31]
|
DFND |
3,112,964.0 |
3,112,964.0 |
Nikko Asset Management Americas Inc |
[2023-03-31]
|
SOLE |
2,735,487.0 |
3,112,964.0 |
Wellington Management Group LLP |
[2023-03-31]
|
DFND |
0.0 |
2,966,140.0 |
Morgan Stanley |
[2023-03-31]
|
DFND |
2,247,348.0 |
2,655,483.0 |
Federated Hermes Inc |
[2023-03-31]
|
DFND |
2,020,079.0 |
2,020,079.0 |
Price T Rowe Associates Inc /MD/ |
[2023-03-31]
|
SOLE |
355,014.0 |
1,794,087.0 |
AllianceBernstein LP |
[2023-03-31]
|
DFND |
1,635,970.0 |
1,764,928.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
1,655,391.0 |
1,655,391.0 |
Viking Global Investors LP |
[2023-03-31]
|
SOLE |
1,569,545.0 |
1,569,545.0 |
Rokos Capital Management LLP |
[2023-03-31]
|
OTR |
0.0 |
1,389,296.0 |
Bank of America Corp /DE/ |
[2023-03-31]
|
DFND |
28,100.0 |
1,341,093.0 |
Casdin Capital LLC |
[2023-03-31]
|
SOLE |
1,275,000.0 |
1,275,000.0 |
Citadel Advisors LLC |
[2023-03-31]
|
DFND |
1,259,114.0 |
1,259,114.0 |
FMR LLC |
[2023-03-31]
|
DFND |
1,200,196.0 |
1,205,657.0 |
Himension Capital Singapore PTE Ltd |
[2023-03-31]
|
SOLE |
1,145,091.0 |
1,145,091.0 |
Nuveen Asset Management LLC |
[2023-03-31]
|
DFND |
1,058,068.0 |
1,058,218.0 |
Pictet Asset Management Sa |
[2023-03-31]
|
DFND |
1.0 |
940,496.0 |
Chevy Chase Trust Holdings, LLC |
[2023-03-31]
|
DFND |
0.0 |
937,066.0 |
Charles Schwab Investment Management Inc |
[2023-03-31]
|
SOLE |
869,172.0 |
869,172.0 |
Goldman Sachs Group Inc |
[2023-03-31]
|
DFND |
847,515.0 |
859,482.0 |
Dimensional Fund Advisors LP |
[2023-03-31]
|
SOLE |
726,302.0 |
768,762.0 |
Northern Trust Corp |
[2023-03-31]
|
DFND |
50,761.0 |
759,739.0 |
Deep Track Capital LP |
[2023-03-31]
|
SOLE |
704,533.0 |
704,533.0 |
JPMorgan Chase & Co |
[2023-03-31]
|
DFND |
501,047.0 |
666,074.0 |
Bioimpact Capital LLC |
[2023-03-31]
|
SOLE |
572,459.0 |
572,459.0 |
Discovery Value Fund |
[2023-03-31]
|
SOLE |
561,561.0 |
561,561.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 120538727, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
163622155